Clinical Trial Update: Romiplostim in Thoracic Transplantation

View source ↗

Summary

A completed clinical trial evaluating romiplostim for thrombocytopenia in thoracic transplantation. Sponsor: Nantes University Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Drugs mentioned

• Romiplostim (romiplostim)

Snippet

Sponsor: Nantes University Hospital | Conditions: Thrombocytopenia | Status: COMPLETED